Page last updated: 2024-09-03

emoxypine succinate and Cerebrovascular Disorders

emoxypine succinate has been researched along with Cerebrovascular Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Kuznetsov, NS; Kuznetsova, EB; Salina, EA1
Kunelskaya, NL; Larionova, EV; Levina, YV; Ogorodnikov, DS; Yanyushkina, ES1
Gudasheva, TA; Povarnina, PY; Seredenin, SB; Volkova, AA1
Gorbunov, FE; Penionzhkevich, DIu1
Antonova, KV; Lagoda, OV; Tanashian, MM1

Other Studies

5 other study(ies) available for emoxypine succinate and Cerebrovascular Disorders

ArticleYear
[Efficacy of Mexidol in the correction of postcovid syndrome in patients with chronic cerebrovascular diseases].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2023, Volume: 123, Issue:5

    Topics: Antioxidants; Asthenia; Cerebrovascular Disorders; Chronic Disease; COVID-19; Humans; Syndrome

2023
[Possibility of application Mexidol for the treatment of patients suffering from sensorineural hearing loss and cerebrovascular insufficiency].
    Vestnik otorinolaringologii, 2019, Volume: 84, Issue:6

    Topics: Antioxidants; Auditory Threshold; Cerebrovascular Disorders; Hearing Loss, Sensorineural; Humans; Picolines; Speech Intelligibility

2019
Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats.
    Bulletin of experimental biology and medicine, 2017, Volume: 164, Issue:2

    Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Dipeptides; Disease Models, Animal; Drug Administration Schedule; Injections, Intraperitoneal; Middle Cerebral Artery; Molecular Mimicry; Neuroprotective Agents; Neurotrophin 3; Picolines; Rats; Rats, Wistar; Stroke

2017
[New technologies of neurometabolic therapy of cerebrovascular diseases].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:7

    Topics: Adult; Aged; Antioxidants; Cerebrovascular Circulation; Cerebrovascular Disorders; Electrophoresis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Organophosphorus Compounds; Picolines; Transcranial Magnetic Stimulation; Treatment Outcome

2009
[Chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:11

    Topics: Aged; Antioxidants; Cerebrovascular Disorders; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Picolines; Treatment Outcome

2012